BIIB  valuation analysis

Basics
Name: Biogen Inc
Description: Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. (more)
Industry: Drug Manufacturers-General
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Oct 20, 2021
Market cap: $34.69B (234th)
Sales(TTM): $11.10B (277th)
Earnings(TTM): $2.11B (169th)

Value
FFER: 1.30 (why)
Actual price: $233.47
FFEThis is Biogen Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $180.04
Quantile: BIIB is expensive given its fundamentals.
Prices as of EOD 2021-12-23
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
Biogen Inc
"Drug Manufacturers-General" industry
Sales / MarketCap
Biogen Inc
"Drug Manufacturers-General" industry
Book / MarketCap
Biogen Inc
"Drug Manufacturers-General" industry
Equity / Assets
Biogen Inc
"Drug Manufacturers-General" industry